MM-141: Clinical Trials

2 trials of MM-141, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow MM-141: new trials by email Literature Review of MM-141 trials Research Report on MM-141

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
MM-151, MM-121, MM-141 - Colorectal Cancer, Non-small Cell Lung Cancer
Phase 1TerminatedMerrimack Pharmaceuticals52015-08-012017-09-05
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
MM-141 - Hepatocellular Carcinoma
Phase 1CompletedMerrimack Pharmaceuticals422012-11-012016-08-04

Conditions studied

Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Insulin-Like Growth Factor I, Resistance To (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Merrimack Pharmaceuticals (2)

Countries

United States (2)  ·  France (1)

Top investigators

Chrystal Louis, MD, MPH (1)